Clinical events occurring within 6 months of SARS-COV-2 infection: multicentre cohort

{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"1- History of symptomatic SARS-CoV-2 infection defined by: A positive RT-PCR result for SARS-CoV-2 OR positive SARS-CoV-2 serology combined with at least one event: - Anosmia occurring after February 2020 - OR CT scan consistent with COVID-19 - OR ? 2 symptoms coinciding with the virology sample, including: asthenia, cough, dyspnoea, fever, myalgia, dysgeusia, diarrhoea AND not present prior to diagnosis 2- AND persistence of at least one symptom present in the first 3 weeks of COVID-19, more than 8 weeks after the first COVID symptoms OR late onset of at least one new symptom at least 3 weeks and not more than 6 months after the first symptoms of SARS-CoV-2 infection 3- First symptoms within the past 6 months on the date of inclusion 4- Beneficiary of a health insurance scheme or the state welfare scheme 5- Having signed an informed consent form at inclusion","clusion_E":""}